| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. MD & General Counsel
1 company
Stephen Michael Ksenak last filed a Form 4 in September 2025, as Sr. MD & General Counsel at OSG. Stephen Michael Ksenak's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 205,256 shares of OSG. Net of sales, the OSG filings show accumulation of 8,000 shares.
Stephen Michael Ksenak has 43 Form 4 filings on record from December 2015 to September 2025, all as Sr. MD & General Counsel at Octave Specialty Group (OSG), 2015–2025.
The 104 reported transactions were 39 option exercises, 36 tax withholdings, 22 option or other derivative awards and 3 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $107K and no sales.
The largest open-market purchase was 5,000 shares of OSG at an average $11.00 on August 7, 2024, about $55K. Twelve months later OSG was down 21%.
Shares as reported in the last Form 4 for each company; the most recent is from September 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.